Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
17%
OVERLAP
BY WEIGHT
10
# OF OVERLAPPING
HOLDINGS
BBP
65
HOLDINGS
16%
ALSO IN CANC
CANC
48
HOLDINGS
21%
ALSO IN BBP
SECTOR DRIFT (BBP minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
BEIGENE LTD. SPONSORED ADR | 2.3% | 2.6% | 2.3% |
 |
ZAI LAB LTD. UNSPONSORED ADR | 2.2% | 2.9% | 2.2% |
|
AMGEN INC | 2.0% | 3.3% | 2.0% |
|
BRIDGEBIO PHARMA, INC. | 1.9% | 4.9% | 1.9% |
|
EXELIXIS INC | 1.8% | 4.1% | 1.8% |
BBP Overweight Relative to CANC
|
INTRA-CELLULAR THERAPIES INC | 2.6% |
|
SAGE THERAPEUTICS INC | 2.2% |
|
AXSOME THERAPEUTICS, INC. | 2.1% |
|
SPRINGWORKS THERAPEUTICS, INC. | 2.1% |
|
HALOZYME THERAPEUTICS INC | 2.1% |
|
TG THERAPEUTICS INC | 2.1% |
|
ASCENDIS PHARMA A/S | 1.8% |
|
PTC THERAPEUTICS INC | 1.8% |
|
DYNAVAX TECHNOLOGIES CORP | 1.8% |
|
MADRIGAL PHARMACEUTICALS, INC. | 1.8% |
BBP Underweight Relative to CANC
 |
ROCHE HOLDINGS LTD-SPONS ADR | -5.3% |
|
ELI LILLY & CO | -5.2% |
|
REVOLUTION MEDICINES, INC. | -4.9% |
|
NOVARTIS AG | -4.4% |
 |
ASTRAZENECA PLC | -4.1% |
 |
MERUS N.V. | -3.8% |
 |
GENMAB A/S SPONSORED ADR | -3.7% |
|
NUVALENT, INC. CLASS A | -3.5% |
|
BRISTOL-MYERS SQUIBB CO | -3.5% |
|
ARCELLX, INC. | -3.1% |